Cargando…

In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ

BACKGROUND: Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Die, Zhang, Yonglan, Yang, Fengqing, Lin, Yexin, Zhang, Qihui, Xia, Zhining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809166/
https://www.ncbi.nlm.nih.gov/pubmed/27076748
http://dx.doi.org/10.4103/0973-1296.177909
_version_ 1782423597934968832
author Gao, Die
Zhang, Yonglan
Yang, Fengqing
Lin, Yexin
Zhang, Qihui
Xia, Zhining
author_facet Gao, Die
Zhang, Yonglan
Yang, Fengqing
Lin, Yexin
Zhang, Qihui
Xia, Zhining
author_sort Gao, Die
collection PubMed
description BACKGROUND: Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous severe side-effects may also occur concomitantly. OBJECTIVE: The PPARγ activation activity of different polar extracts, including petroleum ether, ethyl acetate, n-butanol, residual of ethanol, the precipitate part of water and the supernatant of water extracts, from 37 traditional Chinese medicines were systematically evaluated. MATERIALS AND METHODS: HeLa cells were transiently co-transfected with the re-constructed plasmids of GAL4-PPARγ-ligand binding domain and pGL4.35. The activation of PPARγ by different polarity extracts were evaluated based on the PPARγ transactivation assay and rosiglitazone was used as positive control. RESULTS: Seven medicines (root bark of Lycium barbarum, Anoectochilus sroxburghii, the rhizome of Phragmites australis, Pterocephalus hookeri, Polygonatum sibiricum, fruit of Gleditsia sinensis, and Epimedium brevicornu) were able to significantly activate PPARγ. CONCLUSION: As seven medicines were able to activate PPARγ, the anti-diabetic activity of them is likely to be mediated by this nuclear receptor. SUMMARY: Lots of the tested medicinal products had activation effects on activating PPARγ. Ethyl acetate extracts of root bark of L.barbarum, rhizome of P.saustralis and fruit of G.siasinensis showed good PPARγ activation effect similar or higher than that of positive control, 0.5 μg/mL rosiglitazone. Petroleum ether extracts of A.roxburghii, P. hookeri, P. sibiricum, E.brevicornu also can significantly activate PPARγ, the effects of them were higher than t0.5 μg/mL rosiglitazone. Schisandra chinensis (Turcz.) Baill., the fruit Cornus officinalis Siebold and Zucc., Alisma plantago-aquatica L. and the root of Trichosanthes Kirilowii Maxim., traditional anti-diabetic mediciness in China, had no effects on the activation of PPARγ. Abbreviations used: PPARγ: Peroxisome Proliferator-activated Receptors-γ, TCMs: Traditional Chinese medicines, TZDs: Thiazolidinediones, LBD: Ligand binding domain, DMSO: Dimethyl sulfoxide, FBS: Fetal bovine serum, DMEM: Dulbecco's modified Eagle's medium.
format Online
Article
Text
id pubmed-4809166
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48091662016-04-13 In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ Gao, Die Zhang, Yonglan Yang, Fengqing Lin, Yexin Zhang, Qihui Xia, Zhining Pharmacogn Mag Original Article BACKGROUND: Peroxisome proliferator-activated receptors (PPAR)-γ is widely used as an attractive target for the treatment of type 2 diabetes mellitus. Thiazolidinediones, the agonists of PPARγ, has been popularly utilized as insulin sensitizers in the therapy of type 2 diabetes whereas numerous severe side-effects may also occur concomitantly. OBJECTIVE: The PPARγ activation activity of different polar extracts, including petroleum ether, ethyl acetate, n-butanol, residual of ethanol, the precipitate part of water and the supernatant of water extracts, from 37 traditional Chinese medicines were systematically evaluated. MATERIALS AND METHODS: HeLa cells were transiently co-transfected with the re-constructed plasmids of GAL4-PPARγ-ligand binding domain and pGL4.35. The activation of PPARγ by different polarity extracts were evaluated based on the PPARγ transactivation assay and rosiglitazone was used as positive control. RESULTS: Seven medicines (root bark of Lycium barbarum, Anoectochilus sroxburghii, the rhizome of Phragmites australis, Pterocephalus hookeri, Polygonatum sibiricum, fruit of Gleditsia sinensis, and Epimedium brevicornu) were able to significantly activate PPARγ. CONCLUSION: As seven medicines were able to activate PPARγ, the anti-diabetic activity of them is likely to be mediated by this nuclear receptor. SUMMARY: Lots of the tested medicinal products had activation effects on activating PPARγ. Ethyl acetate extracts of root bark of L.barbarum, rhizome of P.saustralis and fruit of G.siasinensis showed good PPARγ activation effect similar or higher than that of positive control, 0.5 μg/mL rosiglitazone. Petroleum ether extracts of A.roxburghii, P. hookeri, P. sibiricum, E.brevicornu also can significantly activate PPARγ, the effects of them were higher than t0.5 μg/mL rosiglitazone. Schisandra chinensis (Turcz.) Baill., the fruit Cornus officinalis Siebold and Zucc., Alisma plantago-aquatica L. and the root of Trichosanthes Kirilowii Maxim., traditional anti-diabetic mediciness in China, had no effects on the activation of PPARγ. Abbreviations used: PPARγ: Peroxisome Proliferator-activated Receptors-γ, TCMs: Traditional Chinese medicines, TZDs: Thiazolidinediones, LBD: Ligand binding domain, DMSO: Dimethyl sulfoxide, FBS: Fetal bovine serum, DMEM: Dulbecco's modified Eagle's medium. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4809166/ /pubmed/27076748 http://dx.doi.org/10.4103/0973-1296.177909 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gao, Die
Zhang, Yonglan
Yang, Fengqing
Lin, Yexin
Zhang, Qihui
Xia, Zhining
In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title_full In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title_fullStr In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title_full_unstemmed In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title_short In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ
title_sort in vitro screening and evaluation of 37 traditional chinese medicines for their potential to activate peroxisome proliferator-activated receptors-γ
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809166/
https://www.ncbi.nlm.nih.gov/pubmed/27076748
http://dx.doi.org/10.4103/0973-1296.177909
work_keys_str_mv AT gaodie invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg
AT zhangyonglan invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg
AT yangfengqing invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg
AT linyexin invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg
AT zhangqihui invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg
AT xiazhining invitroscreeningandevaluationof37traditionalchinesemedicinesfortheirpotentialtoactivateperoxisomeproliferatoractivatedreceptorsg